164 related articles for article (PubMed ID: 7537029)
1. Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms.
McMahon JB; Currens MJ; Gulakowski RJ; Buckheit RW; Lackman-Smith C; Hallock YF; Boyd MR
Antimicrob Agents Chemother; 1995 Feb; 39(2):484-8. PubMed ID: 7537029
[TBL] [Abstract][Full Text] [Related]
2. Anti-HIV michellamines from Ancistrocladus korupensis.
Boyd MR; Hallock YF; Cardellina JH; Manfredi KP; Blunt JW; McMahon JB; Buckheit RW; Bringmann G; Schäffer M; Cragg GM
J Med Chem; 1994 Jun; 37(12):1740-5. PubMed ID: 8021914
[TBL] [Abstract][Full Text] [Related]
3. Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
McMahon JB; Gulakowski RJ; Weislow OS; Schultz RJ; Narayanan VL; Clanton DJ; Pedemonte R; Wassmundt FW; Buckheit RW; Decker WD
Antimicrob Agents Chemother; 1993 Apr; 37(4):754-60. PubMed ID: 7684215
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant activity of michellamine alkaloids.
White EL; Ross LJ; Hobbs PD; Upender V; Dawson MI
Anticancer Res; 1999; 19(2A):1033-5. PubMed ID: 10368651
[TBL] [Abstract][Full Text] [Related]
5. Michellamine alkaloids inhibit protein kinase C.
White EL; Chao WR; Ross LJ; Borhani DW; Hobbs PD; Upender V; Dawson MI
Arch Biochem Biophys; 1999 May; 365(1):25-30. PubMed ID: 10222035
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors.
Hizi A; Tal R; Shaharabany M; Currens MJ; Boyd MR; Hughes SH; McMahon JB
Antimicrob Agents Chemother; 1993 May; 37(5):1037-42. PubMed ID: 7685994
[TBL] [Abstract][Full Text] [Related]
7. HIV-inhibitory michellamine-type dimeric naphthylisoquinoline alkaloids from the Central African liana Ancistrocladus congolensis.
Bringmann G; Steinert C; Feineis D; Mudogo V; Betzin J; Scheller C
Phytochemistry; 2016 Aug; 128():71-81. PubMed ID: 27137461
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein.
Slepushkin VA; Kornilaeva GV; Andreev SM; Sidorova MV; Petrukhina AO; Matsevich GR; Raduk SV; Grigoriev VB; Makarova TV; Lukashov VV
Virology; 1993 May; 194(1):294-301. PubMed ID: 7683157
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
10. Oxazole-Benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1A and Reduce Viral Replication.
Rawle DJ; Li D; Wu Z; Wang L; Choong M; Lor M; Reid RC; Fairlie DP; Harris J; Tachedjian G; Poulsen SA; Harrich D
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918071
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
Joshi P; Prasad VR
J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
[TBL] [Abstract][Full Text] [Related]
12. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
[TBL] [Abstract][Full Text] [Related]
13. Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide.
Buckheit RW; White EL; Fliakas-Boltz V; Russell J; Stup TL; Kinjerski TL; Osterling MC; Weigand A; Bader JP
Antimicrob Agents Chemother; 1999 Aug; 43(8):1827-34. PubMed ID: 10428899
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
15. U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.
Dueweke TJ; Poppe SM; Romero DL; Swaney SM; So AG; Downey KM; Althaus IW; Reusser F; Busso M; Resnick L
Antimicrob Agents Chemother; 1993 May; 37(5):1127-31. PubMed ID: 7685995
[TBL] [Abstract][Full Text] [Related]
16. Anti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptase.
Fujihashi T; Hara H; Sakata T; Mori K; Higuchi H; Tanaka A; Kaji H; Kaji A
Antimicrob Agents Chemother; 1995 Sep; 39(9):2000-7. PubMed ID: 8540706
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of michellamine B, a naphthylisoquinoline alkaloid with in vitro activity against human immunodeficiency virus types 1 and 2, in the mouse and dog.
Supko JG; Malspeis L
Antimicrob Agents Chemother; 1995 Jan; 39(1):9-14. PubMed ID: 7695336
[TBL] [Abstract][Full Text] [Related]
18. Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2.
Manfredi KP; Blunt JW; Cardellina JH; McMahon JB; Pannell LL; Cragg GM; Boyd MR
J Med Chem; 1991 Dec; 34(12):3402-5. PubMed ID: 1766007
[No Abstract] [Full Text] [Related]
19. Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction.
Bader JP; McMahon JB; Schultz RJ; Narayanan VL; Pierce JB; Harrison WA; Weislow OS; Midelfort CF; Stinson SF; Boyd MR
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6740-4. PubMed ID: 1713689
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct.
Chavan SJ; Bornmann WG; Flexner C; Prochaska HJ
Arch Biochem Biophys; 1995 Dec; 324(1):143-52. PubMed ID: 7503549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
